DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Hydrocortisone Valerate is a drug marketed by Cosette, Glenmark Pharms Ltd, Lupin Ltd, Perrigo Israel, Taro, and Fougera Pharms. and is included in nine NDAs.
The generic ingredient in HYDROCORTISONE VALERATE is hydrocortisone valerate. There are sixty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrocortisone valerate profile page.
A generic version of HYDROCORTISONE VALERATE was approved as hydrocortisone valerate by TARO on August 25th, 1998.